about
Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutatedInnate immune recognition of molds and homology to the inner ear protein, cochlin, in patients with autoimmune inner ear diseaseHyper IgM syndrome associated with defective CD40-mediated B cell activationIL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease.Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED.Illustrative cases on individualizing immunoglobulin therapy in primary immunodeficiency disease.Eczema and thrombocytopenia in an 8-month-old infant boy.Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis.The structure and origin of rheumatoid factors.Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis.Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosisImmune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11.Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.Poly(I:C) induces controlled release of IL-36γ from keratinocytes in the absence of cell death.T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.Monoclonal IgM rheumatoid factors bind IgG at a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3.Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease.Rituximab and immune deficiency: case series and review of the literature.Management of primary antibody deficiency syndromes.Idiotypic network regulations of immune responses to HLA.Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis.Allergen immunotherapy practice patterns: a worldwide survey.Panniculitis and fever in children.Mapping rheumatoid factor binding sites using genetically engineered, chimeric IgG antibodies.X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii.Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis.Clinical ambiguities--ongoing questions.Rheumatologic manifestations of pediatric human immunodeficiency virus infection.Acute undifferentiated leukemia (AUL): a case report and a proposed system of classification.Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants.Common variable hypogammaglobulinemia, recurrent Pneumocystis carinii pneumonia on intravenous gamma-globulin therapy, and natural killer deficiency.Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings.Emerging Paradigm of Primary Immunodeficiency Disease: Individualizing Immunoglobulin Dose and Delivery to Enhance Outcomes.The Importance of Measuring IL10 Levels in Patients with Suspected IL10/IL10R Defects.
P50
Q24608897-780B0D4E-A561-44C0-8BBD-6399103B2AF0Q30429752-10A53298-F8F6-444B-8D75-A2DDE76B6A7FQ30449257-140C8776-32CA-4026-9C55-CC82A2B83FB6Q30471015-22C00C1A-B76D-424C-9C07-66F362025F27Q30490048-2FB45281-1ADE-4DD4-BEA3-179673D11E88Q33411693-AA597E7B-BAF5-4753-A0F7-386B11B237A6Q33498569-3C8DE959-4FBB-4B8B-8EBC-3EBB66763AC4Q33624846-A01E13EC-07E3-4B94-BF25-93796FEF9424Q33712058-C2EEFF12-A861-4D94-AF30-A59A39D3EBF1Q33876995-31E9CA15-3C13-49E1-A2C1-FC0D80A7025BQ34018721-9D2EB84D-85CE-4987-BF05-49B4D1A819BEQ34129757-F8183262-7622-4A80-803D-6E1F221374F3Q34344289-96421D79-DC86-4734-A97A-583A0EA78EFFQ35072682-592E9597-2348-408B-9BAC-5425DA0123B8Q35647677-9D0F7676-DD4F-4B2D-92FF-96F072B1A12CQ35820252-59AAEBFB-2150-47DD-B0C3-B7C4011A2F28Q35871756-D45FA225-AFE2-4449-8BBB-3C3C769CDD4FQ36289982-9748EDA8-CA0F-404B-8404-7CD91143379AQ36465254-33B3DDD8-2409-4258-8253-0BC86D457282Q36757876-2F745DDA-D1EA-45E9-8BB1-64F6D5E7C770Q38070104-3C863BCE-A61E-4E7F-9A27-4B73BAD3A304Q38248470-938B03AC-B967-4DB3-B157-2DA8540F9A25Q39039551-B63F060B-BECA-4D7F-B625-56CF5E1EC806Q39613881-8DFCD514-B5DB-4327-8EAF-5D0ABF2142A6Q39664342-ADA00253-5333-4CB1-8B70-83AF83F9885BQ40037060-EDFD628D-49BE-47B4-B207-1AC8753583DFQ40720673-913A483E-2558-4E09-864E-7AB923E2B1BDQ41779278-7426C77A-83EE-4102-AB30-E0C03313FF4FQ42770597-0268728C-E4FF-41D9-BFD5-447964F433A7Q43574674-280BE0B7-8BA1-48D6-8270-446278CC211AQ44095244-C83A86DF-1998-464E-BC63-A45FAE09AE16Q44593232-B34665BF-96E4-4E75-BD0B-38B904B28456Q44616288-D35FD257-C8C2-47FA-A217-F2311F940CA1Q44649876-CC95DFCF-72A3-4777-82C8-43A800C4173FQ45023089-4E4AC035-FF00-4B02-B751-35DFCCC41EC4Q45795287-D7EE6EB0-B1A7-4C74-8431-A067AE5EC700Q45842807-55DCFC33-B5A4-4FE2-A1FB-EB02CCE28A83Q45863230-5DB05426-A3B1-481C-A101-CB6C63AF46DDQ46004431-6D8B0603-8815-41AA-9535-B48DCA548D85Q48323219-6855D6A9-0BBD-4570-B27B-47BB08CC0C4C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vincent R Bonagura
@ast
Vincent R Bonagura
@en
Vincent R Bonagura
@es
Vincent R Bonagura
@nl
Vincent R Bonagura
@sl
type
label
Vincent R Bonagura
@ast
Vincent R Bonagura
@en
Vincent R Bonagura
@es
Vincent R Bonagura
@nl
Vincent R Bonagura
@sl
prefLabel
Vincent R Bonagura
@ast
Vincent R Bonagura
@en
Vincent R Bonagura
@es
Vincent R Bonagura
@nl
Vincent R Bonagura
@sl
P106
P21
P31
P496
0000-0002-0681-2099